Dr Mary Jane Betterman, MD | |
301 N 11th St, Nebraska City, NE 68410-2031 | |
(952) 595-1100 | |
(612) 294-4903 |
Full Name | Dr Mary Jane Betterman |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 301 N 11th St, Nebraska City, Nebraska |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1710962386 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 21910 (Nebraska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Mary Jane Betterman, MD 11995 Singletree Ln, Suite 500, Eden Prairie, MN 55344-5347 Ph: (952) 595-1301 | Dr Mary Jane Betterman, MD 301 N 11th St, Nebraska City, NE 68410-2031 Ph: (952) 595-1100 |
News Archive
Teva Pharmaceutical Industries Ltd. and Active Biotech today presented data further illuminating the novel, dual mechanism of action (MOA) of investigational oral, once-daily, laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS), conferring neuroprotective and anti-inflammatory properties.
Every day our kidneys tackle the daunting task of continuously cleaning our blood to prevent waste, salt and excess fluid from building up inside our bodies.
A higher rate of mortality is known to be associated with epilepsy, but the precise contribution of the underlying health factors is unknown. The results from the study of a large cohort of people born in Denmark in 1977 through 2006 were reported today at the American Epilepsy Society meeting here.
Half of all young people treated for severe obesity have neuropsychiatric problems, according to a new study by researchers from Lund University and Gothenburg, Sweden, among others. Two thirds of the teens suffered from some type of mental health problem, as reported by themselves or their parents.
Senesco Technologies, Inc., announced today that the characteristics and activity of SNS01 have been released on-line in Molecular Therapy, the official journal of the American Society for Gene & Cell Therapy.
› Verified 9 days ago